Understanding the mechanisms of anaphylaxis
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: The present review considers recent reports that identify the roles of key intermediate signaling components and mediators during and after mast cell activation and degranulation leading to anaphylaxis. RECENT FINDINGS: Mechanisms of anaphylaxis are becoming better understood as the interaction of several regulatory systems in the mast cell activation and degranulation signaling cascade. Multiple tyrosine kinases, activated after immunoglobulin E binding to the high-affinity receptors for immunoglobulin E (FcepsilonRI), exert both positive and negative regulation on the signaling cascade, which may vary with genetic background or mutations in signaling proteins. Calcium influx, the essential, proximal intracellular event leading to mast cell degranulation, is controlled also by both negative and positive regulation through calcium channels. Sphingosine-1-phosphate is emerging as a newly realized mediator of anaphylaxis, acting as a signaling component within the mast cell and as a circulating mediator. SUMMARY: Anaphylaxis is a systemic reaction involving multiple organ systems, but it is believed that it may be influenced by cellular events in mast cells and basophils resulting in the release of mediators. Therefore, understanding the mechanisms of mast cell activation and degranulation is critical to understanding the mechanisms of anaphylaxis. Recent reports have identified important regulatory components of the signaling cascade and, consequently, potential targets for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sampson, H. A., Muñoz-Furlong, A., Campbell, R. L., Adkinson, N. F., Bock, S. A., Branum, A., Brown, S. G. A., Camargo, C. A., Cydulka, R., Galli, S. J., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.12.1303 · Cited by 2,313
Self-citationIntegrated signalling pathways for mast-cell activation
Gilfillan, A. M., & Tkaczyk, C. (2006) · Nature Reviews Immunology · doi:10.1038/nri1782 · Cited by 950
Nagata, H., Worobec, A. S., Oh, C. K., Chowdhury, B. A., Tannenbaum, S., Suzuki, Y., & Metcalfe, D. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10560 · Cited by 872
Self-citationSampson, H. A., Muñoz-Furlong, A., Campbell, R. L., Adkinson, N. F., Allan Bock, S., Branum, A., Brown, S. G. A., Camargo, C. A., Cydulka, R., Galli, S. J., et al. (2006) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2006.01.018 · Cited by 748
Self-citationSymposium on the Definition and Management of Anaphylaxis: Summary report
Sampson, H. A., Muñoz-Furlong, A., Bock, S. A., Schmitt, C., Bass, R., Chowdhury, B. A., Decker, W. W., Furlong, T. J., Galli, S. J., Golden, D. B., et al. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.01.009 · Cited by 641
Self-citationPlatelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis
Vadas, P., Gold, M., Perelman, B., Liss, G. M., Lack, G., Blyth, T., Simons, F. E. R., Simons, K. J., Cass, D., & Yeung, J. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070030 · Cited by 526
Lieberman, P., Camargo, C. A., Bohlke, K., Jick, H., Miller, R. L., Sheikh, A., & Simons, F. E. R. (2006) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)61086-1 · Cited by 481
Anaphylaxis: A review of causes and mechanisms
Kemp, S. F., & Lockey, R. F. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.126811 · Cited by 471
Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation
Parravicini, V., Gadina, M., Kovarova, M., Odom, S., Gonzalez-Espinosa, C., Furumoto, Y., Saitoh, S., Samelson, L. E., O'Shea, J. J., & Rivera, J. (2002) · Nature Immunology · doi:10.1038/ni817 · Cited by 448
Anaphylaxis: Lessons from mouse models
Finkelman, F. D. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.07.033 · Cited by 404
Research works printed but not linked: 1
- Portier, 1902, De l'action anaphylactique de certains venins [The anaphylactic reaction to certain venoms], C R Seances Soc Biol, 54, 170
Cited by
World Allergy Organization Anaphylaxis Guidance 2020
Cardona, V., Ansotegui, I. J., Ebisawa, M., El-Gamal, Y., Fernandez Rivas, M., Fineman, S., Geller, M., Gonzalez-Estrada, A., Greenberger, P. A., Sanchez Borges, M., et al. (2020) · World Allergy Organization Journal · doi:10.1016/j.waojou.2020.100472 · Cited by 1,186
Chromone: A Valid Scaffold in Medicinal Chemistry
Gaspar, A., Matos, M. J., Garrido, J., Uriarte, E., & Borges, F. (2014) · Chemical Reviews · doi:10.1021/cr400265z · Cited by 760
Valent, P., Akin, C., Arock, M., Brockow, K., Butterfield, J. H., Carter, M. C., Castells, M., Escribano, L., Hartmann, K., Lieberman, P., et al. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000328760 · Cited by 654
Self-citationSimons, F. E. R. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.12.981 · Cited by 368
Anaphylaxis: Recent advances in assessment and treatment
Simons, F. E. R. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.08.025 · Cited by 242
“In addition, an array of cytokines and chemokines are synthesized and released, including IL-6, the newly recognized IL-33(42) and TNF-a, which is both a late-phase mediator and a preformed mediator.(35) The opening of the endothelial barrier through endothelial Gq/G11-mediated signaling has been identified as a criti…”
BackgroundNonredundant Roles of Basophils in Immunity
Karasuyama, H., Mukai, K., Obata, K., Tsujimura, Y., & Wada, T. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101257 · Cited by 211
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome
Valent, P., Akin, C., Bonadonna, P., Hartmann, K., Brockow, K., Niedoszytko, M., Nedoszytko, B., Siebenhaar, F., Sperr, W. R., Oude Elberink, J. N. G., et al. (2019) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2019.01.006 · Cited by 225
“The severity of a resulting reaction is also influenced by the number of MCs (and basophils) involved in the event, the nature and number of IgE-reactive allergen(s), the type and amount of IgE, the presence of comorbidities, other patient-related factors (alcohol, nicotine, or illegal substances), the type and amount…”
BackgroundSelf-citationFungi: the neglected allergenic sources
Crameri, R., Garbani, M., Rhyner, C., & Huitema, C. (2014) · Allergy · doi:10.1111/all.12325 · Cited by 207
“In sensitized (atopic) individuals, however, re-exposure to the offending allergen induces crosslinking of the high-affinity receptor FceRI-bound allergenspecific IgE on effector cells and, thus, immediate release of anaphylactogenic mediators (11).”
BackgroundDénes, Á., Ferenczi, S., & Kovács, K. J. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-164 · Cited by 163
“Mice were challenged with LPS or Ova+A 3 h before MCAo to develop a systemic inflammatory response [14-17] by the time experimental stroke was induced.”
MethodManagement of infusion reactions to systemic anticancer therapy: ESMO Clinical Practice Guidelines
Roselló, S., Blasco, I., Fabregat, L. G., Cervantes, A. M. R., & Jordan, K. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx216 · Cited by 168
Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy
Niedoszytko, M., de Monchy, J., van Doormaal, J. J., Jassem, E., & Elberink, J. N. G. O. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.02118.x · Cited by 170
Shmuel, D. L., & Cortes, Y. (2013) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/vec.12066 · Cited by 140
Mast cell activation syndromes: definition and classification
Valent, P. (2013) · Allergy · doi:10.1111/all.12126 · Cited by 120
He, S., Zhang, H., Zeng, X., Chen, D., & Yang, P. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.88 · Cited by 113
Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice
Schäfer, B., Piliponsky, A. M., Oka, T., Song, C. H., Gerard, N. P., Gerard, C., Tsai, M., Kalesnikoff, J., & Galli, S. J. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.05.009 · Cited by 102
“009 Anaphylaxis is a severe acute systemic allergic reaction that can be induced when certain unfortunate subjects previously sensitized to an allergen are later exposed to even very small amounts of that allergen.(1,2) In anaphylaxis the offending antigen interacts with specific IgE antibodies bound to tissue mast ce…”
BackgroundChen, W.-A., Chang, D.-Y., Chen, B., Lin, Y., Barenholz, Y., & Roffler, S. R. (2023) · ACS Nano · doi:10.1021/acsnano.2c12193 · Cited by 105
Valent, P., Akin, C., Nedoszytko, B., Bonadonna, P., Hartmann, K., Niedoszytko, M., Brockow, K., Siebenhaar, F., Triggiani, M., Arock, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239030 · Cited by 92
Self-citationValent, P., Hartmann, K., Bonadonna, P., Gülen, T., Brockow, K., Alvarez-Twose, I., Hermine, O., Niedoszytko, M., Carter, M. C., Hoermann, G., et al. (2022) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2022.05.007 · Cited by 90
Self-citationPathophysiology of anaphylaxis
Khan, B. Q., & Kemp, S. F. (2011) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3283481ab6 · Cited by 104
Clinical reviews in allergy and immunology
Leung, D. Y. M., Ledford, D. K., Wechsler, M. E., Fulkerson, P. C., Bochner, B. S., Gauvreau, G. M., Gleich, G. J., Henkel, T., Kolbeck, R., Mathur, S. K., et al. (2012) · Cited by 87
Corticosteroids in management of anaphylaxis; a systematic review of evidence
Liyanage, C. K., Galappatthy, P., & Seneviratne, S. L. (2017) · European Annals of Allergy and Clinical Immunology · doi:10.23822/eurannaci.1764-1489.15 · Cited by 84
Ozdemir, C., Akdis, M., & Akdis, C. A. (2010) · Chemical Immunology and Allergy · doi:10.1159/000315936 · Cited by 78
TRPA1 Expression and Pathophysiology in Immune Cells
Naert, R., López‐Requena, A., & Talavera, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111460 · Cited by 81
“The release of huge amounts of preformed mediators such as histamine, tryptase, chymase, and proteoglycans can lead to rapid onset of flushing, swelling, shortness of breath, and in severe cases death [79].”
BackgroundMoghimi, S. M. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.11.006 · Cited by 73
Anaphylaxis: Mechanisms of Mast Cell Activation
Kalesnikoff, J., & Galli, S. J. (2010) · Chemical Immunology and Allergy · doi:10.1159/000315937 · Cited by 67
He, Y., Liu, S., Menon, A., Stanford, S. M., Oppong, E. K., Gunawan, A. M., Wu, L., Wu, D. J., Barrios, A. M., Bottini, N., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400248c · Cited by 67
Clarke, R. C., Sadleir, P. H. M., & Platt, P. R. (2012) · Anaesthesia · doi:10.1111/j.1365-2044.2011.06995.x · Cited by 66
les membres de la commission des référentiels de la SFMU, E. E. D. L. S., Gloaguen, A., Cesaréo, E., Vaux, J., Valdenaire, G., Ganansia, O., Renolleau, S., Pouessel, G., Beaudouin, É., Lefort, H., et al. (2016) · Annales françaises de médecine d’urgence · doi:10.1007/s13341-016-0668-2 · Cited by 71
Anaphylaxis: a history with emphasis on food allergy
Boden, S., & Burks, A. W. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01028.x · Cited by 66
“Calcium influx controlled by both positive and negative regulation is essential to mast cell degranulation (21, 24).”
BackgroundManagement of infusion-related reactions in cancer therapy: strategies and challenges
Barroso, A., Estevinho, F., Hespanhol, V. P., Teixeira, E., Ramalho-Carvalho, J., & Araújo, A. (2024) · ESMO Open · doi:10.1016/j.esmoop.2024.102922 · Cited by 85
Two Sides of the Coin: Mast Cells as a Key Regulator of Allergy and Acute/Chronic Inflammation
Zhang, Z., & Kurashima, Y. (2021) · Cells · doi:10.3390/cells10071615 · Cited by 70
The future of biologics: Applications for food allergy
Bauer, R. N., Manohar, M., Singh, A. M., Jay, D. C., & Nadeau, K. C. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.12.1908 · Cited by 63
BTK inhibition is a potent approach to block IgE‐mediated histamine release in human basophils
Smiljkovic, D., Blatt, K., Stefanzl, G., Dorofeeva, Y., Skrabs, C., Focke‐Tejkl, M., Sperr, W. R., Jaeger, U., Valenta, R., & Valent, P. (2017) · Allergy · doi:10.1111/all.13166 · Cited by 59
“The type and severity of an IgE-dependent (anaphylactic) reaction depends on additional variables, including the source and configuration of the allergen, organ-specific factors, and the numbers of BA and MC involved in the reaction.(10-14) BA and MC may increase in number in various immunologic diseases, in certain t…”
BackgroundAssessing anaphylactic risk? Consider mast cell clonality
Metcalfe, D. D., & Schwartz, L. B. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.02.003 · Cited by 52
“Further research is needed to determine if mast cell responsiveness is one determinant of the threshold to elicit an allergic reaction and perhaps the subsequent severity of the allergic inflammatory response.(17) A corollary to this line of thought is that inhibiting the tyrosine kinase activity of activating/mutatio…”
BackgroundSelf-citationFactor XII-Driven Inflammatory Reactions with Implications for Anaphylaxis
Bender, L., Weidmann, H., Rose‐John, S., Renné, T., & Long, A. T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01115 · Cited by 54
“org September 2017 | Volume 8 | Article 1115 platelet-activating factor (PAF), cytokine tumor necrosis factor α, and leukotrienes (37).”
BackgroundValent, P., Horny, H.-P., Triggiani, M., & Arock, M. (2011) · International Archives of Allergy and Immunology · doi:10.1159/000323763 · Cited by 50
Management around invasive procedures in mastocytosis
Hermans, M. A. W., Arends, N. J. T., van Wijk, R. G., van Hagen, P. M., Kluin‐Nelemans, H. C., Elberink, H. N. G. O., Pasmans, S. G. M. A., & van Daele, P. L. A. (2017) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2017.07.022 · Cited by 55
The rationale for development of ligelizumab in food allergy
Wood, R. A., Chinthrajah, R. S., Eggel, A., Bottoli, I., Gautier, A., Woisetschläger, M., Tassinari, P. A., & Altman, P. (2022) · World Allergy Organization Journal · doi:10.1016/j.waojou.2022.100690 · Cited by 45
Food-induced anaphylaxis: mast cells as modulators of anaphylactic severity
Hogan, S. P., Wang, Y. H., Strait, R. T., & Finkelman, F. D. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0320-1 · Cited by 52
Mechanisms Underlying the Skin-Gut Cross Talk in the Development of IgE-Mediated Food Allergy
van Splunter, M. E., Liu, L., van Neerven, R. J. J., Wichers, H. J., Hettinga, K. A., & de Jong, N. W. (2020) · Nutrients · doi:10.3390/nu12123830 · Cited by 51
“Food-induced anaphylaxis is an immediate, adverse reaction, primarily triggered by cross-linking of allergen-specific IgE bound to the high-affinity IgE receptor (FcεRI) on mast cells (MCs) after re-exposure to the same food allergen [15].”
BackgroundRegulation of G-protein-coupled signaling pathways in allergic inflammation
Druey, K. M. (2008) · Immunologic Research · doi:10.1007/s12026-008-8050-0 · Cited by 48
“Although no offending allergens can be determined in patients with IA, mast cell degranulation, and subsequent release of inflammatory mediators is thought to cause the disease [28].”
Anaphylactic Degranulation of Mast Cells: Focus on Compound Exocytosis
Klein, O., & Sagi-Eisenberg, R. (2019) · Journal of Immunological Research · doi:10.1155/2019/9542656 · Cited by 36
Alternative Anaphylactic Routes: The Potential Role of Macrophages
Escribese, M. M., Rosace, D., Chivato, T., Fernández, T. D., Corbí, A. L., & Barber, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00515 · Cited by 40
“Other mediators released during IgE-mediated anaphylaxis are prostaglandins and leukotrienes (17, 20).”
BackgroundAnaphylactic Shock After Indocyanine Green Video Angiography During Cerebrovascular Surgery
Kim, M., Lee, S., Park, J. C., Jang, D., Ha, S. I., Kim, J.-U., Ahn, J. S., & Park, W. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.09.135 · Cited by 40
Serum levels of 9α,11β-PGF2 and cysteinyl leukotrienes are useful biomarkers of anaphylaxis
Nassiri, M., Eckermann, O., Babina, M., Edenharter, G., & Worm, M. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.07.001 · Cited by 36
Garland, J., Ondruschka, B., Broi, U. D., Palmière, C., & Tse, R. D. (2020) · Forensic Science International · doi:10.1016/j.forsciint.2020.110415 · Cited by 35
Mediators Released During Human Anaphylaxis
Stone, S. F., & Brown, S. G. A. (2011) · Current Allergy and Asthma Reports · doi:10.1007/s11882-011-0231-6 · Cited by 40
“Allergen-specific IgE binds to its high-affinity receptor, FcεRI, expressed on effector cells, predominantly mast cells and basophils [22].”
BackgroundBiomarkers of anaphylaxis, beyond tryptase
Sala-Cunill, A., & Cardona, V. (2015) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000184 · Cited by 35
“In humans, anaphylaxis is predominantly due to immediate hypersensitivity reactions, initiated by an allergen interacting with allergen-specific IgE (sIgE) bound to its high-affinity receptor (FceRI) expressed on effector cells, mainly mast cell and basophils [4].”
BackgroundZhao, T., Hu, S., Ma, P., Che, D., Liu, R., Zhang, Y., Wang, J., Li, C., Ding, Y., Fu, J., et al. (2019) · Phytotherapy Research · doi:10.1002/ptr.6385 · Cited by 31
“Therefore, it is believed that the main factor in triggering anaphylaxis is the release of mediators from activated MCs into the bloodstream and then throughout the body (Peavy & Metcalfe, 2008).”
BackgroundHe, F., Wang, H., Du, P., Li, T., Wang, W., Tan, T., Liu, Y., Ma, Y., Wang, Y., & El‐Aty, A. M. A. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.02.005 · Cited by 31
Expression and regulation of Siglec-6 (CD327) on human mast cells and basophils
Smiljkovic, D., Herrmann, H., Sadovnik, I., Gamperl, S., Berger, D., Stefanzl, G., Eisenwort, G., Hoermann, G., Kopanja, S., Dorofeeva, Y., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.07.018 · Cited by 31
Regulatory CD4+Foxp3+ T Cells Control the Severity of Anaphylaxis
Kanjarawi, R., Dy, M., Bardel, É., Sparwasser, T. D., Dubois, B., Mécheri, S., & Kaiserlian, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069183 · Cited by 32
“This leads to the symptomatic effector phase of anaphylaxis, induced MC degranulation and immediate release of preformed mediators such as histamine, mouse mast cell protease-1 (mMCP-1) [2], trypase [3] and platelet-activating factor (PAF) [4] and de novo synthesis of inflammatory mediators such as leukotrienes, prost…”
BackgroundIgE‐based immunotherapy of cancer: challenges and chances
Singer, J., & Jensen‐Jarolim, E. (2013) · Allergy · doi:10.1111/all.12276 · Cited by 35
“As basophils are one of the major sources of histamine and anaphylactic mediators in the circulation during an anaphylactic shock (153), one of the major concerns of passive immunotherapy of cancer with monoclonal IgE antibodies is that intravenously applied IgE sensitizes FceRI on basophils and could potentially be c…”
BackgroundTargeting the FcεRI Pathway as a Potential Strategy to Prevent Food-Induced Anaphylaxis
Dispenza, M. C., Bochner, B. S., & MacGlashan, D. W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.614402 · Cited by 28
“Numerous kinases are involved in FcεRI pathway signaling, including spleen tyrosine kinase (Syk), Bruton’s tyrosine kinase (BTK), Lyn, Fyn, phospholipase Cg (PLCg), PI3 kinase (PI3K), and others (4).”
BackgroundRisk factors for anaphylaxis in patients with mastocytosis
Górska, A., Niedoszytko, M., Lange, M., Chełmińska, M., Nedoszytko, B., Wasąg, B., Słomiński, J. M., Gruchała‐Niedoszytko, M., Nowicki, R. J., & Jassem, E. (2015) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.2644 · Cited by 28
Mertès, P., Bazin, A., Alla, F., Bienvenu, J., Caldani, C., Lamy, B., Laroche, D., Floris, M., Py, J.-Y., Rebibo, D., et al. (2011) · PubMed · Cited by 27
Identification of Soluble Mediators in IgG-Mediated Anaphylaxis via Fcγ Receptor: A Meta-Analysis
Kow, A. S. F., Chik, A., Soo, K.-M., Khoo, L. W., Abas, F., & Tham, C. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00190 · Cited by 28
“81 ng/ml is also an inflammatory soluble mediator and is released as both pre-formed and late-phase mediator and has the ability to activate neutrophils, recruits other effector cells and enhances the synthesis of chemokine (34).”
BackgroundAcute Urticaria and Anaphylaxis: Differences and Similarities in Clinical Management
Ensina, L. F., Min, T. K., Félix, M. M. R., de Alcântara, C. T., & Costa, C. (2022) · Frontiers in Allergy · doi:10.3389/falgy.2022.840999 · Cited by 32
“Activation of mast cells occurs when allergen-specific IgE is bound by allergen and interacts with high-affinity IgE receptor (FcεRI) on their surfaces (9).”
BackgroundBlatt, K., Herrmann, H., Mirkina, I. I., Hadzijusufovic, E., Peter, B., Strommer, S., Hoermann, G., Mayerhofer, M., Höetzenecker, K., Klepetko, W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029925 · Cited by 28
“Likewise, in advanced SM, patients suffer not only from the aggressive and sometimes devastating infiltration of MC, but also from mediator-related symptoms [11–13].”
Background(2023) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2023.07.001 · Cited by 25
Self-citationPEST‐domain‐enriched tyrosine phosphatase and glucocorticoids as regulators of anaphylaxis in mice
Obiri, D. D., Flink, N., Maier, J. V., Neeb, A., Maddalo, D., Thiele, W., Menon, A., Stassen, M., Kulkarni, R. A., Garabedian, M. J., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02731.x · Cited by 25
“As calcium mobilization plays an essential proximal role in intracellular events leading to mast cell degranulation and anaphylaxis (17), studies on antigen-stimulated degranulation (histamine release) were carried out.”
BackgroundAurora kinase inhibitor tozasertib suppresses mast cell activation in vitro and in vivo
Zhang, L., Ji, K., Sun, Y., Hou, Y., & Chen, J. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15012 · Cited by 28
“IgE/Ag stimulation involves IgE cross-linking with FcεRI cell surface receptors (Peavy & Metcalfe, 2008), whereas PAMCI induction involves activation of cell surface GPCRs and consequent influx of calcium, which activates downstream signalling (Chen et al., 2017).”
BackgroundKitaoka, M., Naritomi, A., Kawabe, Y., Kamihira, M., Kamiya, N., & Goto, M. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10048 · Cited by 24
Molecular Pathways Linking Oxylipins to Nociception in Rats
Domenichiello, A. F., Sapio, M. R., Loydpierson, A. J., Maric, D., Goto, T., Horowitz, M. S., Keyes, G. S., Yuan, Z., Majchrzak‐Hong, S. F., Mannes, A. J., et al. (2020) · Journal of Pain · doi:10.1016/j.jpain.2020.09.001 · Cited by 24
The Initial Common Pathway of Inflammation, Disease, and Sudden Death
Davidson, R. M., & Seneff, S. (2012) · Entropy · doi:10.3390/e14081399 · Cited by 24
“…[244], acute pancreatitis [245], acute pituitary necrosis [246], pseudomembranous colitis, thrombotic thrombocytopenic purpura (TTP), Sanarelli-Shwartzman phenomenon (SSP), Henoch-Schonlein purpura (HSP), eclampsia [238], serum sickness, hemolytic anemia, preeclampsia, and stillbirths [247].”
Tan, J. W., Israf, D. A., Harith, H. H., Hashim, N. F. M., Ng, C. H., Shaari, K., & Tham, C. L. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.02.002 · Cited by 29
Spinacetin Suppresses the Mast Cell Activation and Passive Cutaneous Anaphylaxis in Mouse Model
Ji, N., Pan, S., Shao, C., Chen, Y., Zhang, Z., Wang, R., Qiu, Y., Jin, M., & Kong, D. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00824 · Cited by 23
A Puzzling Mast Cell Trilogy: Anaphylaxis, MCAS, and Mastocytosis
Gülen, T. (2023) · Diagnostics · doi:10.3390/diagnostics13213307 · Cited by 24
“…also known as “releasability”, depends on several factors, including the underlying (primary) disease/pathology, the numbers and type of activated surface receptors, the signaling pathways involved, the type and route of allergen exposure, and the amount of allergen-specific IgE [12,54–57].”
BackgroundPühringer, V., Jilma, B., & Herkner, H. (2023) · Frontiers in Allergy · doi:10.3389/falgy.2023.1249280 · Cited by 26
“This leads to immunologic reactions such as vasodilation and increased vascular permeability (2 – 4).”
BackgroundSingh, R. S., Kaur, H. P., Rana, V., & Kennedy, J. F. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.12.036 · Cited by 20
The Crosstalk between FcεRI and Sphingosine Signaling in Allergic Inflammation
Jo, H., Shim, K., & Jeoung, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213892 · Cited by 22
“S1P acts as a signaling component within the MCs [82].”
BackgroundUsing the Right Criteria for MCAS
Gülen, T. (2024) · Current Allergy and Asthma Reports · doi:10.1007/s11882-024-01126-0 · Cited by 24
“Systemic activation of MCs encompasses the conditions of anaphylaxis and MC activation syndrome (MCAS) [12–14].”
BackgroundManaging the Student With Severe Food Allergies
Robinson, J. M., & Ficca, M. (2011) · The Journal of School Nursing · doi:10.1177/1059840511429686 · Cited by 20
“The release of histamine from mast cells leads to cardiovascular symptoms such as vasodilation and increased vascular permeability, while bronchoconstriction results from the secretion of leukotrienes and prostaglandin D2 (Peavy & Metcalfe, 2008).”
BackgroundDeveloping food allergy: a potential immunologic pathway linking skin barrier to gut
Wang, Y. (2016) · F1000Research · doi:10.12688/f1000research.9497.1 · Cited by 22
Wittenberg, M., Nassiri, M., Francuzik, W., Lehmann, K., Babina, M., & Worm, M. (2017) · Allergy · doi:10.1111/all.13176 · Cited by 20
“Anaphylaxis is a rapid potentially life-threatening allergic reaction.(1,2) Preformed and de novo synthesized mediators,(3) predominantly released by activated mast cells (MCs), or basophils 4 determine the outcome of this response.”
BackgroundInhibitory effects of orientin in mast cell-mediated allergic inflammation
Dhakal, H., Lee, S., Choi, J. K., Kwon, T. K., Khang, D., & Kim, S. (2020) · Pharmacological Reports · doi:10.1007/s43440-019-00048-3 · Cited by 21
Fisiopatología de la alergia alimentaria
Reyes-Pavón, D., Jiménez, M., & Salinas, E. (2020) · Revista Alergia México · doi:10.29262/ram.v67i1.731 · Cited by 24
Research Advances in Mast Cell Biology and Their Translation Into Novel Therapies for Anaphylaxis
Dispenza, M. C., Metcalfe, D. D., & Olivera, A. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.03.015 · Cited by 18
Self-citationBorahay, M. A., Harirah, H. M., Olson, G., Kilic, G. S., Karipcin, S., & Hankins, G. (2011) · American Journal of Perinatology Reports · doi:10.1055/s-0030-1271219 · Cited by 18
“There are also a significant number of anaphylaxis cases reported for which there is no cause identified (idiopathic anaphylaxis).(5) Although anaphylaxis is a rare event during pregnancy, it has the potential to lead to serious maternal and/ or fetal morbidity.”
BackgroundGórska, A., Gruchała‐Niedoszytko, M., Niedoszytko, M., Maciejewska, A., Chełmińska, M., Skrzypski, M. T., Wasąg, B., Kaczkan, M., Lange, M., Nedoszytko, B., et al. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0397-7 · Cited by 19
“However, the presence of KIT gene mutations, notably D816V, detectable in more than 90 % of patients with systemic mastocytosis resulting in an increased activation of mast cells, does not correlate with the severity or the prevalence of anaphylaxis (Peavy and Metcalfe 2008).”
BackgroundAnaphylaxis: Mediators, Biomarkers, and Microenvironments
Fernandez-Bravo, S., Palacio-Garcia, L., Requena-Robledo, N., Yuste-Montalvo, A., Nuñez-Borque, E., & Esteban, V (2022) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0854 · Cited by 17
Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors
Kalkusova, K., Smite, S., Darras, E., Táborská, P., Stakheev, D., Vannucci, L. E., Bartůňková, J., & Smrž, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911080 · Cited by 19
“This receptor induces a fast degranulation of MCs, often referred to as anaphylactic degranulation since the content of the released granules are preformed mediators such as histamine, proteases, and heparin [25], which are responsible for anaphylaxis [26,27].”
BackgroundBell, K. S., Al‐Riyami, L., Lumb, F. E., Britton, G. J., Poole, A. W., Williams, C. M., Braun, U., Leitges, M., Harnett, M. M., & Harnett, W. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.09.001 · Cited by 18
Wang, Y., Ding, Y., Li, C., Gao, J., Wang, X., & An, H. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108449 · Cited by 20
Current Concepts in Resuscitation
Pieracci, F. M., Biffl, W. L., & Moore, E. E. (2011) · Journal of Intensive Care Medicine · doi:10.1177/0885066610394318 · Cited by 18
The Influence of IgE on Cultured Human Mast Cells
Frandsen, P. M., Krohn, I. K., Hoffmann, H. J., & Schiøtz, P. O. (2013) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2013.5.6.409 · Cited by 17
“The release of these immunoreactive substances result in increased vascular permeability, contraction of smooth muscles surrounding the airways (bronchoconstriction) and enhances chemokine production.(1) IgE antibodies against a wide variety of different antigens are normally present in small amounts in the blood stre…”
BackgroundThe Targets of IgE: Allergen-Associated and Tumor-Associated Molecular Patterns
Jensen‐Jarolim, E., Mechtcheriakova, D., & Pali‐Schöll, I. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-451-7_10 · Cited by 16
Akin, C., Siebenhaar, F., Wechsler, J. B., Youngblood, B. A., & Maurer, M. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.03.010 · Cited by 19
Diagnostic Utility of Biomarkers in Anaphylaxis: A Systematic Review and Meta-Analysis
Khalaf, R., Prosty, C. J., Davalan, W., Abrams, E. M., Kaouache, M., & Ben‐Shoshan, M. (2025) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2025.04.008 · Cited by 24
Anti-adhesion and Anti-inflammatory Potential of the Leaderless Class IIb Bacteriocin Enterocin DD14
Teiar, R., Pérez-Ramos, A., Zgheib, H., Cudennec, B., Belguesmia, Y., & Drider, D. (2022) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-022-09954-0 · Cited by 15
“The inflammatory reaction sometimes can lead to unexpected effects like immunity disorders, autoimmune diseases, or anaphylaxis [18, 19].”
BackgroundHoriuchi, T., Takazawa, T., Haraguchi, T., Orihara, M., Nagumo, K., & Saito, S. (2023) · Journal of Anesthesia · doi:10.1007/s00540-023-03199-z · Cited by 15
Ursolic acid inhibits FcεRI-mediated mast cell activation and allergic inflammation
Dhakal, H., Kim, M.-J., Lee, S., Choi, Y., Kim, N.-K., Kwon, T. K., Khang, D., & Kim, S. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107994 · Cited by 14
Combined use of ECMO and hemodialysis in the case of contrast-induced biphasic anaphylactic shock
Sugiura, A., Nakayama, T., Takahara, M., Sugimoto, K., Hattori, N., Abe, R., Fujimoto, Y., Oda, S., & Kobayashi, Y. (2016) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2016.02.039 · Cited by 14
Drug‐induced anaphylaxis in the emergency room
Takazawa, T., Oshima, K., & Saito, S. (2017) · Acute Medicine & Surgery · doi:10.1002/ams2.282 · Cited by 17
Kim, K. J., Song, Y., Park, S., Oh, S. J., & Kwon, S. J. (2022) · Bulletin of the Korean Chemical Society · doi:10.1002/bkcs.12641 · Cited by 13
Park, M., Song, Y., Kim, K. J., Oh, S. J., Ahn, J. K., Park, H., Shin, H.-B., & Kwon, S. J. (2020) · Biosensors · doi:10.3390/bios10040038 · Cited by 13
Yong, S., Chen, H., Huang, J., & Wei, J. C. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14532 · Cited by 13
Kościuczuk, U., & Knapp, P. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1976818 · Cited by 12
“This explains the frequent occurrence of hypersensitivity reactions to muscle relaxants during patients’ first anaesthesia experience [47,49].”
BackgroundWawrzyniak, M., Pich-Bavastro, C., Gross, B. S., Schütz, F., Fleury, S., Quemener, S., Sgandurra, M., Bouchaert, E., Moret, C., Mury, L., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.11.006 · Cited by 12
Boutin, R. C. T., Dwyer, Z., Farmer, K., Rudyk, C., Forbes, M. R., & Hayley, S. P. (2018) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-018-0263-8 · Cited by 12
Metadata
- Authors
- Peavy, R. D., & Metcalfe, D. D.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Peavy, Richard D
- ORCID
- Metcalfe, Dean D
- Venue
- Current Opinion in Allergy & Clinical Immunology
- Published
- 2008-08
- Volume
- 8
- Issue
- 4
- Pages
- 310-315
- ISSN
- 1473-6322 (ISSN-L)
- 1528-4050
- PMC
- PMC2683407
- OpenAlex
- W2043965664
- Cited by
- 211
- References
- 50
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 14 · 2023: 22 · 2022: 14 · 2021: 18 · 2020: 10 · 2019: 9 · 2018: 11 · 2017: 16 · 2016: 10 · 2015: 10 · 2014: 5 · 2013: 10 · 2012: 9
- FWCI
- 0.74
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Current Opinion in Allergy and Clinical Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (NIH0013412243)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- anaphylaxis, mast cell activation, mast cell degranulation, FcεRI, immunoglobulin E, tyrosine kinase, calcium influx, calcium channels, sphingosine-1-phosphate, basophils, signaling regulation, therapeutic target
- MeSH terms
- Anaphylaxis, Animals, Humans, Immunoglobulin E, Lysophospholipids, Mast Cells, Sphingosine, Calcium Channels, Signal Transduction, Cell Degranulation, Inflammation Mediators, src-Family Kinases, Mastocytosis, Systemic, Proto-Oncogene Proteins c-fyn, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.